Eculazumab (SOLIRIS) 10MG/ML X8
Ended Awarded Last action
- Contract number
- VA25116F1088
- Awardee
-
Alexion Pharmaceuticals Inc. UEI DKCXLGANZAN3
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $35,840
Award facts
- Opportunity
-
- 553-16-2-090-0265 Eculazumab (Soliris) 10mg/ml inj Award Notice · Posted Mar 1, 2016
- Contract value 100% obligated
- $35,839.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Detroit, MI 48201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $523 | |
| Original award | $35,317 |
Quick answers
Who was awarded contract VA25116F1088?
VA25116F1088 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on February 29, 2016.
How much is contract VA25116F1088 worth?
The government has obligated $35,840 on VA25116F1088.
Is contract VA25116F1088 an order under another contract?
Yes. VA25116F1088 is a delivery order under V797D30015, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA25116F1088 competed?
The extent of competition for VA25116F1088 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award